TearLab (NASDAQ:TEAR) will report earnings after markets close on Monday, May 13th. TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.
Here is your Cheat Sheet to Tearlab Earnings:
Earnings Expectations: Analysts expect earnings of $-0.12 per share on revenues of $2.18 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.09 to a loss $0.12. For the current year, the average estimate is a loss of $0.43, which is worse than the estimate ninety days ago.
Here’s how Tearlab has been performing on an annual basis:
|Revenue ($) in millions||0.46||0.87||1.70||2.12||3.96|
|Diluted EPS ($)||-2.29||-0.44||-0.47||-0.50||-0.76|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||0.50||0.42||0.72||1.21||1.61|
|Diluted EPS ($)||-0.1699||-0.44||-0.10||-0.17||-0.1276|
Tearlab has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)